Literature DB >> 26246404

Sphingosine-1-phosphate inhibits IL-1-induced expression of C-C motif ligand 5 via c-Fos-dependent suppression of IFN-β amplification loop.

Jessie W Yester1, Lauren Bryan1, Michael R Waters1, Bartosz Mierzenski1, Debolina D Biswas1, Angela S Gupta1, Reetika Bhardwaj1, Michael J Surace1, Jose M Eltit1, Sheldon Milstien1, Sarah Spiegel1, Tomasz Kordula2.   

Abstract

The neuroinflammation associated with multiple sclerosis involves activation of astrocytes that secrete and respond to inflammatory mediators such as IL-1. IL-1 stimulates expression of many chemokines, including C-C motif ligand (CCL) 5, that recruit immune cells, but it also stimulates sphingosine kinase-1, an enzyme that generates sphingosine-1-phosphate (S1P), a bioactive lipid mediator essential for inflammation. We found that whereas S1P promotes IL-1-induced expression of IL-6, it inhibits IL-1-induced CCL5 expression in astrocytes. This inhibition is mediated by the S1P receptor (S1PR)-2 via an inhibitory G-dependent mechanism. Consistent with this surprising finding, infiltration of macrophages into sites of inflammation increased significantly in S1PR2(-/-) animals. However, activation of NF-κB, IFN regulatory factor-1, and MAPKs, all of which regulate CCL5 expression in response to IL-1, was not diminished by the S1P in astrocytes. Instead, S1PR2 stimulated inositol 1,4,5-trisphosphate-dependent Ca(++) release and Elk-1 phosphorylation and enhanced c-Fos expression. In our study, IL-1 induced the IFNβ production that supports CCL5 expression. An intriguing finding was that S1P induced c-Fos-inhibited CCL5 directly and also indirectly through inhibition of the IFN-β amplification loop. We propose that in addition to S1PR1, which promotes inflammation, S1PR2 mediates opposing inhibitory functions that limit CCL5 expression and diminish the recruitment of immune cells. © FASEB.

Entities:  

Keywords:  GPCR; astrocytes; chemokines; inflammation

Mesh:

Substances:

Year:  2015        PMID: 26246404      PMCID: PMC4653053          DOI: 10.1096/fj.15-275180

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  62 in total

1.  CCL5, CXCL10 and CXCL11 chemokines in patients with active and stable relapsing-remitting multiple sclerosis.

Authors:  Adam Szczuciński; Jacek Losy
Journal:  Neuroimmunomodulation       Date:  2010-08-19       Impact factor: 2.492

Review 2.  Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis.

Authors:  Volker Brinkmann; Andreas Billich; Thomas Baumruker; Peter Heining; Robert Schmouder; Gordon Francis; Shreeram Aradhye; Pascale Burtin
Journal:  Nat Rev Drug Discov       Date:  2010-10-29       Impact factor: 84.694

3.  Molecular and in silico characterization of a promoter module and C/EBP element that mediate LPS-induced RANTES/CCL5 expression in monocytic cells.

Authors:  S Fessele; S Boehlk; A Mojaat; N G Miyamoto; T Werner; E L Nelson; D Schlondorff; P J Nelson
Journal:  FASEB J       Date:  2001-01-05       Impact factor: 5.191

4.  The interleukin-1 cluster gene region is associated with multiple sclerosis in an Italian Caucasian population.

Authors:  I Borzani; M R Tola; L Caniatti; A Collins; G De Santis; D Luiselli; E Mamolini; C Scapoli
Journal:  Eur J Neurol       Date:  2010-02-23       Impact factor: 6.089

5.  G-protein-coupled receptor agonists differentially regulate basal or tumor necrosis factor-alpha-stimulated activation of interleukin-6 and RANTES in human airway smooth muscle cells.

Authors:  Chien-Da Huang; Alaina J Ammit; Omar Tliba; Han-Pin Kuo; Raymond B Penn; Reynold A Panettieri; Yassine Amrani
Journal:  J Biomed Sci       Date:  2005-11-09       Impact factor: 8.410

6.  Crystal structure of ATF-2/c-Jun and IRF-3 bound to the interferon-beta enhancer.

Authors:  Daniel Panne; Tom Maniatis; Stephen C Harrison
Journal:  EMBO J       Date:  2004-10-28       Impact factor: 11.598

7.  Interleukin 1 genotypes in multiple sclerosis and relationship to disease severity.

Authors:  C L A Mann; M B Davies; V L Stevenson; S M Leary; M D Boggild; C Ko Ko; P W Jones; A A Fryer; R C Strange; A J Thompson; C P Hawkins
Journal:  J Neuroimmunol       Date:  2002-08       Impact factor: 3.478

8.  Interleukin-1beta induction of the chemokine RANTES promoter in the human astrocytoma line CH235 requires both constitutive and inducible transcription factors.

Authors:  N G Miyamoto; P S Medberry; J Hesselgesser; S Boehlk; P J Nelson; A M Krensky; H D Perez
Journal:  J Neuroimmunol       Date:  2000-06-01       Impact factor: 3.478

9.  Fos and Jun repress transcription activation by NF-IL6 through association at the basic zipper region.

Authors:  W Hsu; T K Kerppola; P L Chen; T Curran; S Chen-Kiang
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

10.  A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis.

Authors:  Caroline Sutton; Corinna Brereton; Brian Keogh; Kingston H G Mills; Ed C Lavelle
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

View more
  9 in total

Review 1.  Sphingolipids and Lymphomas: A Double-Edged Sword.

Authors:  Alfredo Pherez-Farah; Rosa Del Carmen López-Sánchez; Luis Mario Villela-Martínez; Rocío Ortiz-López; Brady E Beltrán; José Ascención Hernández-Hernández
Journal:  Cancers (Basel)       Date:  2022-04-19       Impact factor: 6.575

Review 2.  Immediate Early Gene c-fos in the Brain: Focus on Glial Cells.

Authors:  Fernando Cruz-Mendoza; Fernando Jauregui-Huerta; Adriana Aguilar-Delgadillo; Joaquín García-Estrada; Sonia Luquin
Journal:  Brain Sci       Date:  2022-05-24

3.  Sphingosine 1-Phosphate Receptors in Cerebral Ischemia.

Authors:  Bhakta Prasad Gaire; Ji Woong Choi
Journal:  Neuromolecular Med       Date:  2020-09-10       Impact factor: 3.843

4.  Divergence of Intracellular Trafficking of Sphingosine Kinase 1 and Sphingosine-1-Phosphate Receptor 3 in MCF-7 Breast Cancer Cells and MCF-7-Derived Stem Cell-Enriched Mammospheres.

Authors:  Olga A Sukocheva; Dong Gui Hu; Robyn Meech; Anupam Bishayee
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

Review 5.  CCL5-Glutamate Cross-Talk in Astrocyte-Neuron Communication in Multiple Sclerosis.

Authors:  Anna Pittaluga
Journal:  Front Immunol       Date:  2017-09-04       Impact factor: 7.561

6.  S1P2-Gα12 Signaling Controls Astrocytic Glutamate Uptake and Mitochondrial Oxygen Consumption.

Authors:  Deepa Jonnalagadda; Yasuyuki Kihara; Richard Rivera; Jerold Chun
Journal:  eNeuro       Date:  2021-07-16

7.  Sphingosine Kinase 1 Regulates the Survival of Breast Cancer Stem Cells and Non-stem Breast Cancer Cells by Suppression of STAT1.

Authors:  Ling-Wei Hii; Felicia Fei-Lei Chung; Chun Wai Mai; Zong Yang Yee; Hong Hao Chan; Vijay Joseph Raja; Noah Elias Dephoure; Nigel J Pyne; Susan Pyne; Chee-Onn Leong
Journal:  Cells       Date:  2020-04-04       Impact factor: 6.600

8.  A Functionally Defined In Vivo Astrocyte Population Identified by c-Fos Activation in a Mouse Model of Multiple Sclerosis Modulated by S1P Signaling: Immediate-Early Astrocytes (ieAstrocytes).

Authors:  Aran Groves; Yasuyuki Kihara; Deepa Jonnalagadda; Richard Rivera; Grace Kennedy; Mark Mayford; Jerold Chun
Journal:  eNeuro       Date:  2018-09-24

Review 9.  Besieging the Tumoral Sites: Could It Be an Alternative Therapeutic Strategy in Ductal Pancreatic Adenocarcinoma?

Authors:  Mohamed Islam Delma
Journal:  Cureus       Date:  2020-10-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.